Search the Newsreel

News | Bristol Myers Squibb plans $2.3 billion Houston campus

Bristol Myers Squibb announced plans for a $2.3 billion, 600,000-square-foot campus in Houston's Generation Park, expected to create nearly 500 skilled jobs by 2030. This investment is part of a larger $40 billion commitment to U.S. operations, aiming to boost domestic manufacturing and reduce …

Is Schrödinger (SDGR) Undervalued Following Its Profit Turn And Bristol Myers Squibb Deal?

Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston

Bristol Myers Squibb has announced a $2.3 billion investment to build a manufacturing campus in Houston, significantly increasing its initial estimate of $1 billion. The facility, expected to employ nearly 500 people and be completed by 2030, will produce small molecules, biologics, and antibody-drug …

BMS Chooses Houston for $2.3B Manufacturing Facility

Bristol Myers Squibb (BMS) has selected Houston as the location for a new $2.3 billion multi-modal manufacturing campus. This facility, part of BMS's $40 billion U.S. investment, will support the production of various treatments including small molecules, biologics, and ADCs. The campus aims to …

Pharma giant bets $2.3B on massive new Houston campus

Bristol Myers Squibb has chosen Houston for a new $2.3 billion manufacturing campus at Generation Park. This massive 600,000-square-foot facility is expected to create nearly 500 skilled jobs and approximately 2,000 indirect jobs during its construction phase. The investment is part of the company's …

New Bristol Myers Squibb facility coming to Generation Park

Global biopharmaceutical company Bristol Myers Squibb is set to establish a new pharmaceutical manufacturing campus in the Houston area, specifically near Generation Park. FOX 26's Karys Belger reported on this development. The facility will mark a significant expansion for the company in the region.

Bristol Myers Squibb to expand in Harris County

The article states that Bristol Myers Squibb plans to expand its operations in Harris County. No further details are provided regarding the nature or scope of this expansion.

BofA initiates Csquare stock with buy on data center growth

BofA Securities has initiated coverage on Csquare Inc (NYSE:CSQR) with a Buy rating and a price target of $46.00, suggesting a significant upside. The firm's investment thesis is based on the inability of data center supply to meet demand, Csquare's ability to quickly address …

Palmer Square Capital BDC Inc. (PSBD) CCO reports 1,854-share holding on Form 3

Palmer Square Capital BDC Inc.'s Chief Compliance Officer, Ben Wiesenfeld, has filed an initial statement of beneficial ownership (Form 3) reporting a direct holding of 1,854 shares of common stock. This filing indicates Wiesenfeld's initial stake in the company and does not reflect any …

Csquare (CSQR) grows H1 2026 revenue to $550.8M but loss widens on debt load

GameSquare FY26 Q2 net loss widens to $10.6 million; revenue more than doubled to $18.5 million

GameSquare reported a significant increase in revenue for Q2 2026, more than doubling to $18.5 million, while its GAAP net loss widened to $10.6 million. Despite the loss, gross margin improved to 49%, and non-GAAP adjusted EBITDA turned positive at $1 million. The company …

Csquare, Inc. Q2 2026: Revenue $280.4M, EPS $(0.47) — 10-Q Summary

Csquare, Inc. reported its second-quarter 2026 results, showing a 15% increase in revenue to $280.4 million compared to the previous year. However, the company's net loss widened significantly to $48.8 million, resulting in a diluted loss per share of $(0.47). Revenue growth was primarily …

BRISTOL-MYERS SQUIBB AKTIE: AI-Analysen, Prognose & Kursziel

Esquire Financial (ESQ) director exercises 20,000 options, uses 1,902 shares for costs

Esquire Financial Holdings, Inc. director Anthony Coelho exercised 20,000 stock options at $12.50 per share on August 7, 2026. For payment of the exercise price or tax liability, 1,902 shares were delivered or withheld at $131.38 per share. Following this transaction, Coelho holds 12,910 …

Oxford Square Capital Corp. (OXSQ) details Q2 2026 NAV and CLO-heavy portfolio

Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas

Bristol Myers Squibb is investing $2.3 billion to construct a new drug manufacturing campus in Houston, Texas, creating nearly 500 initial jobs and 2,000 construction jobs. The 600,000-square-foot facility at Generation Park will produce various next-generation medicines. Texas Governor Greg Abbott praised the investment, …

Esquire Financial Holdings Inc (ESQ) Stock News Today

This article provides current stock information for Esquire Financial Holdings Inc (ESQ), including its latest trading price, market capitalization, and P/E TTM ratio. It notes that more news is coming soon for ESQ, suggesting that this page serves as a hub for updates regarding …

Esquire Financial Holdings 2Q 2026: Revenue $41.3M, EPS $1.49— 10-Q Summary

Esquire Financial Holdings reported strong results for the second quarter ended June 30, 2026, with total interest income of $41.3M, net income of $13M, and diluted EPS of $1.49, all surpassing year-ago figures. This growth was driven by significant loan expansion in high-yield litigation …

Esquire Financial (Nasdaq: ESQ) boosts H1 2026 profit and closes $466M Signature deal

Bristol Myers Squibb to build $2.3 billion Houston campus

Bristol Myers Squibb announced Monday it will build a $2.3 billion drug manufacturing campus in Houston, Texas, part of the company's broader $40 billion commitment to invest in the United States over five years. The roughly 600,000-square-foot campus will be located at Generation Park, …

Bristol Myers Squibb selects Generation Park for new $2.3B manufacturing campus

Bristol Myers Squibb has chosen Generation Park in northeast Houston for its new $2.3 billion manufacturing campus, a project anticipated to create nearly 500 jobs directly and 2,000 construction jobs. The 600,000-square-foot facility will produce various medicines, supporting the company's $40 billion investment in …

GameSquare Holdings prepares Q2 2026 earnings report amid losses and new growth partnerships

GameSquare Holdings, Inc. is expected to report a loss of $0.03 per share and $17.15 million in revenue for Q2 2026, facing financial challenges like a negative P/E ratio and low current ratio. To combat these issues and drive growth, the company has forged …

Bristol Myers Squibb opening pharmaceutical manufacturing campus near Houston

Bristol Myers Squibb is establishing a new $2.3 billion pharmaceutical manufacturing campus in Generation Park near Houston, expected to create nearly 500 new permanent jobs and 2,000 construction jobs. This marks the second major pharmaceutical investment in the area, following Eli Lilly's plans for …

Bristol Myers To Invest $2.3 Bln In Houston Manufacturing Campus; To Create 500 Skilled Jobs

(RTTNews) - Bristol Myers Squibb (BMY) announced Monday an investment of approximately $2.3 billion in the U.S., while selecting Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus to accelerate the delivery of next-generation medicines to patients. The approximately 600,000 square …

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb announced a $2.3 billion investment to construct a new manufacturing facility in Houston, Texas, creating nearly 500 skilled jobs and approximately 2,000 construction jobs. This initiative is part of the company's $40 billion commitment to U.S. investments and aligns with a …

CSQUARE INC : BOFA GLOBAL RESEARCH INITIATES COVERAGE WITH BUY RATING; PRICE OBJECTIVE $46

BofA Global Research has initiated coverage on CSQUARE INC (CSQR.N) with a Buy rating. The firm has set a price objective of $46 for the company's stock. This news indicates a positive outlook from BofA Global Research regarding CSQUARE INC's future performance.

CSQR Initiated by Wells Fargo -- Rating Set to Overweight with P

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

New State-of-the-Art Facility Will Create Nearly 500 Skilled Jobs and Accelerate the Delivery of Next-Generation Medicines Investment Furthers BMS' $40 Billion Commitment to American Innovation, Manufacturing and Economic Growth PRINCETON, N.J., August 10, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, …

Madison Square Garden Sports (MSGS) Q4 2026 Preview: EPS Est. $0.63, Reports August 13

CSQR Initiated Coverage by BMO Capital -- Rating Set to Outperfo

RBC Initiates Csquare at Outperform With $24 Price Target

RBC Capital Markets has initiated coverage of Csquare, Inc. (CSQR) with an "Outperform" rating and a price target of $24. This follows a series of other analyst initiations and positive ratings for the digital infrastructure platform provider. Csquare, which recently completed a $1.05 billion …

Townsquare Reports Second Quarter 2026 Results; Digital Advertising Revenue Accelerates to 11% Growth Year-Over-Year

Townsquare Media, Inc. reported its second quarter 2026 financial results, highlighting accelerated digital advertising revenue growth of 11% year-over-year. The company's digital businesses now represent 57% of net revenue and 59% of segment profit in the first half of 2026, driven by growth in …

Wells Fargo initiates Csquare stock coverage with overweight rating

Wells Fargo has initiated coverage on Csquare Inc (NYSE:CSQR) with an overweight rating and a price target of $25.00, implying a 16% upside from its current price. The firm anticipates Csquare will surpass peer growth in EBITDA and AFFO per share, despite acknowledging risks …

RBC Capital initiates Csquare stock with outperform rating

RBC Capital initiated coverage on Csquare Inc (NYSE:CSQR) with an Outperform rating and a $24.00 price target, highlighting the company's role as the only SMID-cap option in the public datacenter universe. Despite a significant debt burden, RBC Capital sees an attractive de-levering story due …

BioNTech Aktie: 613 Millionen von Bristol Myers Squibb erwartet

BMO starts Csquare stock at Outperform on data center growth

BMO Capital initiated coverage on Csquare Inc (NYSE:CSQR) with an Outperform rating and a $26.00 price target, citing the company's data center growth, efficient capacity expansion, and deleveraging potential. Despite concerns about high leverage and portfolio quality, BMO believes the current valuation discounts these …